Shanghai-based EpimAb Biotherapeutics has raised $120 million in Series C funding led by CMB International and Korea’s Mirae Asset Financial Group.
Hony Capital, Cormorant Asset Management, Yanchuang Capital, Octagon Capital, ShangBay Capital, and Adrian Cheng - whose family owns Hong Kong-listed New World Development - also took part. Investors such...
Japanese healthcare technology start-up Ubie has closed its Series C round on JPY6.3bn (USD 43.2m) with the latest tranche featuring PE-owned pharmacy chain operator Sogo Medical.
Specialist food and agriculture investor Proterra Investment Partners has agreed to invest in Aperion Bioenergy, a Singapore-based bioenergy producer that sources used cooking oil for feedstocks.
Dymon Asia Private Equity (DAPE) has closed its third Southeast Asia middle market private equity fund at a hard cap of USD 650m, beating a target of USD 550m.
Gamurs, a Sydney-headquartered media company specialising in gaming, e-sports, and entertainment, has secured USD 12m in Series A funding.